ライフサイエンスコーパス: cardiovascular function

1 effects on human health, including decreased cardiovascular function.

2 ygen-sensing machinery that underlies global cardiovascular function.

3 n obligate role for GR in maintaining normal cardiovascular function.

4 micals were screened for targeted effects on cardiovascular function.

5 hannels play a prominent role in controlling cardiovascular function.

6 p influence both cortical brain activity and cardiovascular function.

7 ctivating protein, is strongly implicated in cardiovascular function.

8 te cardiac RyR2 phosphorylation critical for cardiovascular function.

9 OR and that aberrant denitrosylation impairs cardiovascular function.

10 odulate food intake, motivation, stress, and cardiovascular function.

11 BNP in experimental HF resulted in improved cardiovascular function.

12 re to pravastatin did not affect fetal basal cardiovascular function.

13 ety of messengers that are key regulators of cardiovascular function.

14 lation and the effects of corticosteroids on cardiovascular function.

15 ough which ambient temperature may influence cardiovascular function.

16 a unique pathway for the redox regulation of cardiovascular function.

17 t is imperative to determine their impact on cardiovascular function.

18 rol of breathing and in autonomic control of cardiovascular function.

19 ication that may have significant effects on cardiovascular function.

20 imental effects on metabolic homeostasis and cardiovascular function.

21 lar linkage between the serum BDNF level and cardiovascular function.

22 plays an important role in the regulation of cardiovascular function.

23 nformation with ongoing autonomic control of cardiovascular function.

24 T-1 has important implications for renal and cardiovascular function.

25 t and selective Galpha(q) GAP that modulates cardiovascular function.

26 votal role of this enzyme in many aspects of cardiovascular function.

27 d CVLM might also play a role in integrating cardiovascular function.

28 s solitarii (NTS) participates in modulating cardiovascular function.

29 mittent hypoxia (CIH)-induced alterations in cardiovascular function.

30 onses with an underlying circadian rhythm in cardiovascular function.

31 uronal substances that subsequently modulate cardiovascular function.

32 he dietary isoflavones in soy protein affect cardiovascular function.

33 triculography to determine rest and exercise cardiovascular function.

34 at ACTH may play a role in the regulation of cardiovascular function.

35 ates effects of the Arg16Gly polymorphism on cardiovascular function.

36 te the sympathetic nervous system control of cardiovascular function.

37 termittent fasting on glucose regulation and cardiovascular function.

38 bryo development, postnatal growth and later cardiovascular function.

39 llular event in central Ang II regulation of cardiovascular function.

40 uction of the gas, thereby maintaining basal cardiovascular function.

41 ance to the regulation of blood pressure and cardiovascular function.

42 es or markers associated with hepatorenal or cardiovascular function.

43 an important mechanism in the regulation of cardiovascular function.

44 elective sites for pharmacological tuning of cardiovascular function.

45 important area in the central regulation of cardiovascular function.

46 of the beneficial effects that VD exerts on cardiovascular function.

47 n that estrogen produces negative effects on cardiovascular function.

48 e, among others, modulation of autonomic and cardiovascular function.

49 xygen, without any significant impairment in cardiovascular function.

50 o involved in regulating sleep, arousal, and cardiovascular function.

51 he nCom may play a role in the regulation of cardiovascular function.

52 sm of this important enzyme participating in cardiovascular function.

53 pressor area (CVLM) in regulating/modulating cardiovascular function.

54 used 8 noninvasive measures of autonomic and cardiovascular function.

55 relaxin should be considered a regulator of cardiovascular function.

56 ic, this review is focused on its effects on cardiovascular function.

57 ides a mechanism for the rapid regulation of cardiovascular function.

58 AG mediate the ability of the IL to regulate cardiovascular function.

59 , possibly critical, aspects with respect to cardiovascular function.

60 ecies have emerged as important molecules in cardiovascular function.

61 localized in areas of brain more related to cardiovascular function.

62 des in the central nervous system control of cardiovascular function.

63 r regulation of both breathing and autonomic cardiovascular function.

64 urrent and subsequently to the modulation of cardiovascular function.

65 in genes whose functions underlie mammalian cardiovascular function.

66 gic neurotransmission and central control of cardiovascular function.

67 the basolateral amygdala (BLA) in regulating cardiovascular function.

68 omponent of the NO-cGMP pathway, critical to cardiovascular function.

69 indicating dysregulation of post-exertional cardiovascular function.

70 nd norepinephrine, which are known to affect cardiovascular function.

71 lopmental cardiac abnormalities and impaired cardiovascular function.

72 earchers and clinicians to better understand cardiovascular function.

73 processes ranging from neurotransmission to cardiovascular function.

74 nervous systems in regard to control of the cardiovascular function.

75 s been linked to beneficial effects on human cardiovascular function.

76 etal hypoxia, growth restriction and altered cardiovascular function.

77 eful tool for the quantitative evaluation of cardiovascular function.

78 y tuning heart rates is critical for regular cardiovascular function.

79 uption of sympathetic pathways that modulate cardiovascular function.

80 ical alterations, including perturbations in cardiovascular function.

81 gulation of metabolic homeostasis, governing cardiovascular function.

82 bles is converted into NO in vivo to improve cardiovascular function.

83 significant short- and long-term effects on cardiovascular function.

84 cle oxidative capacity and improving certain cardiovascular functions.

85 enes implicated in cell cycle, motility, and cardiovascular functions.

86 al and plays a role in the neural control of cardiovascular functions.

87 rs (5-HTRs) play critical roles in brain and cardiovascular functions.

88 la following transient focal ischemia affect cardiovascular functions.

89 gulation of insulin-regulated metabolism and cardiovascular functions.

90 where they were found in nuclei having known cardiovascular functions.

91 eight but only induce modest improvements in cardiovascular functions.

92 role in the regulation of blood pressure and cardiovascular functions.

93 tant regulator of body fluid homeostasis and cardiovascular functions.

94 ychosocial factors may promote healthy adult cardiovascular functioning.

95 ons observed in HFpEF and sex differences in cardiovascular function across the adult lifespan.

96 emonstrated significantly less impairment of cardiovascular function after biphasic defibrillation.

97 oxygenated HBOC-201 rapidly restored viable cardiovascular function after exsanguinating cardiac arr

98 ective study, we investigated the changes in cardiovascular function after kidney donation.

99 Fast Fourier transformation of cardiovascular function allowed the relative power of th

100 S), a tissue RAS having an important role in cardiovascular function also exists in the central nervo

101 Androstenediol administration improves cardiovascular function and attenuates proinflammatory c

102 here is an increasing need for understanding cardiovascular function and blood flow control in normal

103 ioactivity, conferring beneficial effects on cardiovascular function and blood flow.

104 lyl cyclase (sGC) plays an important role in cardiovascular function and catalyzes formation of cGMP.

105 APJ) system is involved in the regulation of cardiovascular function and central control of body home

106 atory cycle that is required for both normal cardiovascular function and circulatory adaptation to hy

107 eriments, providing a new connection between cardiovascular function and core temperature.

108 metabolites in pathways that are integral to cardiovascular function and disease, including inflammat

109 erstanding of the diverse roles miRs play in cardiovascular function and disease, we applied high-thr

110 ven to be a powerful technology for studying cardiovascular function and disease.

111 tensin type 1a receptors (AT1a) to influence cardiovascular function and energy homeostasis.

112 n injuries must quickly restore and maintain cardiovascular function and fluid balance while minimizi

113 r benefits of lycopene in the maintenance of cardiovascular function and health.

114 tors and effectors of BMP signalling control cardiovascular function and how the dysregulated BMP sig

115 Hot weather taxes cardiovascular function and is associated with increased

116 is a key hormonal system which regulates the cardiovascular function and is implicated in several aut

117 ell known for its profound direct effects on cardiovascular function and metabolism.

118 he effects of glucocorticoids on fetal basal cardiovascular function and on the fetal cardiovascular

119 or other nephrotoxic agents, and optimizing cardiovascular function and oxygen delivery.

120 s long-acting glycemic control with improved cardiovascular function and reduced tissue toxicity in m

121 exogenous ELA or Apelin-13 infusion improves cardiovascular function and survival after cecal ligatio

122 al treatment with dexamethasone alters basal cardiovascular function and the cardiovascular response

123 act with environmental variables to modulate cardiovascular function and the response to therapeutic

124 s and underscore their physiological role in cardiovascular function and their clinical relevance to

125 t phosphodiesterase-5 inhibitors may enhance cardiovascular function and thus exercise capacity in he

126 nicotine inhalation during pregnancy impairs cardiovascular function and uterine hemodynamics with co

127 by brain regions that are known to regulate cardiovascular function and which are activated by chron

128 e has been reported to restore the depressed cardiovascular functions and cell-mediated immune respon

129 y the autonomic nervous system in modulating cardiovascular functions and in controlling blood pressu

130 em are Ras-like G-proteins linked to diverse cardiovascular functions and pathophysiology.

131 es, including metabolism, feeding behaviors, cardiovascular functions and reproduction.

132 s system (CNS)-mediated effects of ANG II on cardiovascular functions and water intake.

133 antisense RNA1, a noncoding gene related to cardiovascular function) and rs269868-C/Ser1067 in DUOX2

134 e been implicated as important modulators of cardiovascular function, and APJ receptor agonists may b

135 data into clinically relevant indicators of cardiovascular function, and estimate hemodynamic variab

136 rstanding of how mutations affect developing cardiovascular function, and few studies have been perfo

137 e is a well-known regulator of metabolic and cardiovascular functions, and signaling through thyroid

138 ts by which leptin regulates food intake and cardiovascular function are differentially influenced by

139 Some aspects of cardiovascular function are impaired in patients with CR

140 in cell-cycle regulation, but their roles in cardiovascular function are poorly understood.

141 Techniques for exploring aspects of cardiovascular function are well developed for larger an

142 the notion that hypothalamic influences upon cardiovascular functions are in part mediated through hy

143 , where GPCRs regulate such core measures of cardiovascular function as heart rate, contractility, an

144 ardiovascular models represent a snapshot of cardiovascular function at a given post-transplant recov

145 erse consequences for NO bioavailability and cardiovascular function at adulthood, and whether neonat

146 he ability to identify chemicals that target cardiovascular function at nonteratogenic concentrations

147 Its role in regulating cardiovascular function at rest and with stress is uncle

148 ired for tachycardia during stress or normal cardiovascular function at rest.

149 s to screen and identify chemicals affecting cardiovascular function at sublethal, nonteratogenic con

150 al benefits in exercise capacity ( VO2max ), cardiovascular function at submaximal and maximal exerci

151 Continued improvement in cardiovascular function before start of day 2 and start

152 ate with each other to integrate and balance cardiovascular function between hemispheres.

153 Circadian rhythmicity of many aspects of cardiovascular function-blood pressure, coagulation and

154 or chronic intermittent cold stress modifies cardiovascular function both under resting conditions an

155 ates numerous biological processes including cardiovascular function, bowel motility, ejaculatory lat

156 ced hypertension, not only maintaining basal cardiovascular function, but also permitting blockade of

157 E2 regulates cardiovascular function, but specific mechanisms, protec

158 supports the actions of statins in improving cardiovascular function, but the mechanisms of their pro

159 as a neuropeptide to control food intake and cardiovascular functions, but its neural role in glucose

160 t regulate stress responses, metabolism, and cardiovascular function by activating either of two rela

161 nverting enzyme (ACE) has a critical role in cardiovascular function by cleaving the carboxy terminal

162 nd suggest a mechanism for the modulation of cardiovascular function by estrogen in women.

163 a pivotal role in the central regulation of cardiovascular function by regulating other renin-angiot

164 ers of inflammation, metabolic function, and cardiovascular function (C-reactive protein, hemoglobin

165 Parameters of cardiovascular function can be measured in mice noninvas

166 Oxygen uptake ( VO2 ) and cardiovascular function (cardiac output ( Q ); stroke vo

167 nitric oxide (NO.), is a novel regulator of cardiovascular function, combining concomitant positive

168 Cardiovascular function declined starting at 20 h postex

169 Analysis of their cardiovascular function demonstrated normal heart functi

170 Cardiovascular function depends on patent blood vessel f

171 ation (AM/AMBP-1) after hemorrhage, improves cardiovascular function despite the increased levels of

172 im was to systematically evaluate changes in cardiovascular function during acute allergic reactions

173 ts a role for this K(ATP) channel subunit in cardiovascular function during conditions of stress.

174 e skeletal muscle pump and vasodilatation on cardiovascular function during exercise, we determined l

175 sleep-disordered breathing or improved sleep cardiovascular function during hGH therapy.

176 this substitution differentially influenced cardiovascular function during short duration (9 min) lo

177 Liver diseases can affect cardiovascular function during the early stages of disea

178 heir proinflammatory secretome also improves cardiovascular function, enhances insulin sensitivity, a

179 Daily rhythms in cardiovascular function ensure that increased delivery o

180 We measured cardiovascular function every 4-6 months for up to 5 yea

181 chanism for the disrupted NE homeostasis and cardiovascular function evident in OI patients with the

182 n index of mood (hypohedonia; Experiment 1), cardiovascular function (Experiment 2), and plasma elect

183 e physiological processes of blood pressure, cardiovascular function, fluid secretion, and others: me

184 ior hypoglycemic effect while also improving cardiovascular function for the patients.

185 The integrated cardiovascular function gain in the exercise group incre

186 The dog, as a model for cardiovascular function, has been widely used in the pha

187 Adenosine, long known as a regulator of cardiovascular function, has recently been identified as

188 g enzyme (ACE)2 in brain regions controlling cardiovascular function; however, the role of ACE2 in bl

189 a mitigate the adverse effects of seizure on cardiovascular function in a rat model of temporal lobe

190 iations between ambient pollution levels and cardiovascular function in a repeated measures study inc

191 spring renin-angiotensin system activity and cardiovascular function in a sperm and/or seminal plasma

192 to assess fetal and infant (6 months of age) cardiovascular function in ART pregnancies.

193 reatment improved circulating parameters and cardiovascular function in both models, and restored SER

194 n to increase NO bioavailability and improve cardiovascular function in both preclinical and clinical

195 nin may play an important role in preserving cardiovascular function in CHF.

196 s, allowing for detailed characterization of cardiovascular function in genetically engineered mice,

197 ly enriched by estrogen, which may influence cardiovascular function in health and disease.

198 defense reflexes on sleep and vigilance and cardiovascular function in healthy individuals.

199 effects of phosphodiesterase 5 inhibitors on cardiovascular function in heart failure (HF) patients,

200 thesised that sildenafil also protects fetal cardiovascular function in hypoxic development.

201 generation of reactive oxygen species alter cardiovascular function in individuals with elastin hapl

202 short episode of postnatal undernutrition on cardiovascular function in mice at the whole animal, org

203 the feasibility of determining parameters of cardiovascular function in mice noninvasively by high-te

204 nociception significantly without affecting cardiovascular function in normotensive animals.

205 maternal treatment with allopurinol on fetal cardiovascular function in ovine pregnancy in late gesta

206 nd below the normal trajectory may influence cardiovascular function in postnatal life.

207 pproach permits the monitoring of changes in cardiovascular function in response to pharmacologic int

208 that progesterone can improve the depressed cardiovascular function in sex steroid-deficient female

209 The data show that development of cardiovascular function in the equine fetus occurs via c

210 However, whether statins affect cardiovascular function in the fetus is completely unkno

211 patient-specific models are used to predict cardiovascular function in the form of right and left ve

212 the mechanisms underlying the development of cardiovascular function in the horse fetus, with particu

213 nutrition in rat gestation adversely affects cardiovascular function in the offspring.

214 We examined whether BDNF in nTS modulates cardiovascular function in vivo and regulates synaptic a

215 VEGF-A and PDGF signalling in vitro, but its cardiovascular function in vivo remains relatively unexp

216 ne in endothelial cells on NO production and cardiovascular function in vivo using NOSTRIN knockout m

217 We evaluated cardiovascular function in young euglycemic Dpp4(-/-) mi

218 the two TSP variants are likely to influence cardiovascular functions in distinct but yet pathogenic

219 resent treatments for the loss or failure of cardiovascular function include organ transplantation, s

220 rmined in vivo longitudinal changes in fetal cardiovascular function including parallel measurement o

221 Estrogen has important effects on cardiovascular function including regulation of vascular

222 In KO mice, resting cardiovascular function, including blood pressure, heart

223 n to exert a number of beneficial effects on cardiovascular function, including reduction in BP and i

224 variety of physiological processes including cardiovascular function, inflammatory responses, and noc

225 (SP), a peptide that has been implicated in cardiovascular function, inflammatory responses, and noc

226 Cardiovascular function is associated with an abnormal p

227 vestigating sex differences in mechanisms of cardiovascular function is highlighted by the National I

228 at our understanding of the role of COX-2 in cardiovascular function is incomplete.

229 (CVD), but investigation of its influence on cardiovascular function is limited.

230 Although astronauts' cardiovascular function is normal while they are in spac

231 In contrast to mammals, cardiovascular function is not essential for early zebra

232 art can induce exosome secretion to modulate cardiovascular function is not known.

233 Cardiovascular function is regulated at multiple levels.

234 The importance of RVLM in the regulation of cardiovascular function is well established.

235 ldosterone is a known regulator of renal and cardiovascular function, its role as a regulator of canc

236 ial to influence parasympathetic outflow and cardiovascular function, likely through an enkephalinerg

237 ing in mnTS plays a tonic role in regulating cardiovascular function, likely via modulation of primar

238 iac vagal activity play significant roles in cardiovascular function, little is known about the synap

239 I have any salutary effects on the depressed cardiovascular function, liver damage, and mortality rat

240 important for the control of food intake and cardiovascular function, making them good candidates to

241 teenagers, these studies raise concern that cardiovascular function may be especially vulnerable dur

242 cts in adult offspring include impairment of cardiovascular function, metabolic derangement and accel

243 five centers studying longitudinal lung and cardiovascular function of infants from HIV-infected mot

244 , and myeloid cells further to elucidate the cardiovascular function of this enzyme.

245 The physiology-in particular, cardiovascular function-of giraffes has therefore captiv

246 valuation of the pharmacological response of cardiovascular function on model animals is important es

247 inically significant adverse drug effects on cardiovascular function or growth at the end of 2 years

248 protein diet had minimal effects on paternal cardiovascular function or renin-angiotensin system acti

249 lcNAc stimulation improves global animal and cardiovascular function outcomes associated with a resto

250 the roles carried out by these molecules in cardiovascular function, pain, epilepsy, migraine and de

251 nucleus (PVN), a critical neuroregulator of cardiovascular function, plays an important role in the

252 Changes in parameters and predicted cardiovascular function post-transplant are used to eval

253 entricular valves corresponded with impaired cardiovascular function (reduced ventricular beat rate a

254 isms by which PKGI kinase activity regulates cardiovascular function remain incompletely understood.

255 is neurohormonal system in neural control of cardiovascular function remains poorly understood.

256 Secondary outcomes included measures of cardiovascular function, renal function, resource use, a

257 ess, suggests that the maintenance of normal cardiovascular function requires elevated cardiac sympat

258 atic processes, such as endocrine secretion, cardiovascular function, salt intake, and nociception.

259 gulation for sympathetic activity to improve cardiovascular function.SIGNIFICANCE STATEMENT Disruptio

260 in the regulation of various cAMP-dependent cardiovascular functions, such as calcium handling and v

261 ave been implicated in regulating neural and cardiovascular functions, such as cell spreading and che

262 rn of distribution and the lack of effect on cardiovascular function support the concept that RASONs

263 ive protein, fibrinogen, IL-6, and albumin), cardiovascular functioning (systolic and diastolic blood

264 Lambs were chronically instrumented and cardiovascular function tested in vivo.

265 (Ang II) has powerful modulatory actions on cardiovascular function that are mediated by specific re

266 a potentially beneficial effect of COX-2 on cardiovascular function that could be negated by COX-2 i

267 pharmacological therapy to improve impaired cardiovascular function that occurs in the context of he

268 and AMPH produced dose-related increases in cardiovascular function that were of comparable magnitud

269 ity of exosomes containing a key receptor in cardiovascular function, the angiotensin II type I recep

270 mechanisms underlies the effects of aging on cardiovascular function, the most important being excess

271 in the regulation of salt-water balance and cardiovascular function: the renin-angiotensin-aldostero

272 (AP) as been implicated in the regulation of cardiovascular function, there is no consensus regarding

273 up is predicted to play a role in regulating cardiovascular function, these findings suggest that dev

274 he NTS, NO from eNOS in the NTS may modulate cardiovascular function through an interaction between a

275 and participate in EA-related modulation of cardiovascular function through an opioid or serotonergi

276 iovascular well-being, programming offspring cardiovascular function through both sperm and seminal p

277 contribute to blood pressure regulation and cardiovascular function through its effects on the vascu

278 ular mechanisms underlying the regulation of cardiovascular functions through baroreceptor function.

279 rticoid-driven maturational changes in fetal cardiovascular function under basal and stressful condit

280 rtical and subcortical brain regions control cardiovascular function via the sympathetic and parasymp

281 Cardiovascular function was evaluated and heart and bloo

282 re and after (R) HDBR while an assessment of cardiovascular function was performed during HDBR.

283 Resting cardiovascular function was similar between the 2 groups

284 Fetal cardiovascular function was stimulated with increasing b

285 Second, cardiovascular function was studied during low/high PEEP

286 Focusing on musculoskeletal and cardiovascular function, we discuss this model and the p

287 are important in the regulation of renal and cardiovascular function, we studied the cardiovascular c

288 f maternal allopurinol on maternal and fetal cardiovascular function were also investigated following

289 a levels of peptides and hormones related to cardiovascular function were also measured.

290 Craving, negative emotion, anxiety, and cardiovascular function were assessed at baseline, immed

291 l administration of Xe-enriched solutions on cardiovascular function were evaluated in vivo.

292 Major determinants of cardiovascular function were impaired in chemotherapy-tr

293 quences of variations in natural BW on basal cardiovascular function were investigated in pigs at 3 m

294 0% of body weight) on CNS function, mood and cardiovascular functioning were measured.

295 o the dorsolateral PAG and did not influence cardiovascular function when injected into the vlPAG of

296 serve capacity involving multiple domains of cardiovascular function, which contribute in an integrat

297 gh-intensity exercise training on integrated cardiovascular function, which incorporates the dynamic

298 The patients maintained stable cardiovascular function while receiving the maximal dose

299 pressure (via radial arterial tonometry) and cardiovascular function with echocardiographic measures

300 frequently limited by an inability to assess cardiovascular function within the intact organism.